A redox-responsive strategy using mesoporous silica nanoparticles for co-delivery of siRNA and doxorubicin
{{output}}
Co-delivery of gene and drug therapies for cancer treatment remains a major goal of nanocarrier research. In this study, mesoporous silica nanoparticles (MSNs) were used to co-deliver siRNA and doxorubicin (Dox) for redox-controlled release. The present nanoca... ...
